Understanding the benefits of universal plasma and cryoprecipitate in hospitals in England

Documenti analoghi

• Comparison of whole blood versus red blood cells and plasma to correct trauma‐induced coagulopathy ex vivo
  di: Andrea Rossetto, et al.
  Pubblicazione: (2025)
• Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange
  di: Florian Tupin, et al.
  Pubblicazione: (2026)
• Transfusion service staff and anesthesiologists prefer pathogen‐reduced cryoprecipitate over conventional cryoprecipitated antihemophilic factor
  di: Robert A. DeSimone, et al.
  Pubblicazione: (2025)
• Establishing a sustainable protocol for massive transfusion using thawed plasma and cryoprecipitate reconstituted from expired thawed plasma
  di: Shigeko Nishimura, et al.
  Pubblicazione: (2026)
• Survey of cryoprecipitate production and cryoprecipitate and fibrinogen concentrate utilization in North America: Variable practices observed from July 2016 to June 2021, The BEST Collaborative Study
  di: Wen Lu, et al.
  Pubblicazione: (2025)